…nd Recurrence after curative-intent resection remains common in hepatocellular carcinoma (HCC), and whether postoperative incretin-based treatment choic…
type 2 diabetes
This disease is selected. Its supporting articles are shown below.
Articles mentioning type 2 diabetes
316 articles · page 12 of 27…mprove glycaemic control (HbA1c) and weight in individuals with type 2 diabetes (T2D). Few studies have explored both the quantitative effects …
…mvirate to the ominous octet and beyond, the pathophysiology of type 2 diabetes (T2D) has been progressively expanded to integrate an increasin…
…sis impairs glucagon-mediated amino acid turnover, resulting in hyperaminoacidemia and compensatory hyperglucagonemia.8In light of these experimen…
…Type 2 diabetes is a pathological condition characterised by impaired glucose m…
…59; p<0.001). (IDDF2026-ABS-0326 Figure 1. Clinical outcomes in chronic pancreatitis GLP-1 RA vs control)Conclusions The use of GLP-1 receptor agoni…
…tension, obesity/overweight, COPD, MASLD/MASH, liver cirrhosis, hepatocellular carcinoma, cardiovascular disease, chronic kidney disease, non-liver canc…
…kground Energy-restricted diets are a cornerstone treatment for metabolic dysfunction-associated steatotic liver disease (MASLD), yet the circulating proteomic changes accompanying hepatic ste…
…NT-1 trial investigators. Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy. N Engl J Med 2025;393:325-35.…
…hest rates of hypertension (60.2%), type 2 diabetes (31.8%) and chronic kidney disease (23.3%). This phenotype portended the poorest 6-year survival (…
…is a progressive condition that may lead to liver cirrhosis and hepatocellular carcinoma. It is strongly associated with cardiometabolic diseases such a…
…Background Upper abdominal cancers, comprising oesophageal, gastric, and pancreatic malignancies, …